Christine Erikstrup Hallgreen

Keyphrases

1. Benefit-risk Assessment 100%
2. Risk-benefit 50%
3. Risk-benefit Ratio 42%
4. Risk Assessment Methods 38%
5. Postprandial State 33%
6. Healthcare Professionals 33%
7. Educational Settings 33%
8. Perception of Use 33%
9. Non-esterified Fatty Acids 33%
10. Anti-obesity 33%
11. Visceral Fat 33%
12. Total Body Fat 33%
13. Visual Representation 33%
14. Postmarket 33%
15. Glucose-insulin Control 33%
16. Medicine Use 33%
17. Adverse Events 33%
18. Real-world Experience 33%
19. Communication Factors 33%
20. Serious Adverse Events 33%
21. Professional Communication 33%
22. Factor Study 33%
23. Postmarketing 33%
24. Visceral Adipose Tissue 33%
25. EudraVigilance 33%
26. Allometric Relationships 33%
27. Fat Mass 25%
28. Warfarin 25%
29. Benefit-risk Communication 22%
30. Estimation Method 17%
31. Randomized Clinical Trial 16%
32. Atrial Fibrillation 16%
33. Adverse Event Reporting 16%
34. Placebo 16%